CORRESP Filing
Alpha Tau Medical Ltd.
Date: June 30, 2025 · CIK: 0001871321 · Accession: 0001213900-25-059491
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288240
Letter
June 30, 2025
Via EDGAR Transmission
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention: Margaret Sawicki
Re: Alpha Tau Medical Ltd.
Registration Statement on Form F-3
Filed June 23, 2025
File No. 333-288240
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement so that it will become effective on July 2, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, or at such later time as Alpha Tau Medical Ltd. (the " Company ") or its counsel may request via telephone call to the staff. Please contact Nathan Ajiashvili of Latham & Watkins LLP, counsel to the Company, at +1.212.906.2916, or in his absence, Joshua G. Kiernan at +44.20.7710.5820, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
[ Signature Page Follows ]
Sincerely yours,
Alpha Tau Medical Ltd.
Show Raw Text
CORRESP 1 filename1.htm June 30, 2025 Via EDGAR Transmission United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Margaret Sawicki Re: Alpha Tau Medical Ltd. Registration Statement on Form F-3 Filed June 23, 2025 File No. 333-288240 Ladies and Gentlemen: In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement so that it will become effective on July 2, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, or at such later time as Alpha Tau Medical Ltd. (the " Company ") or its counsel may request via telephone call to the staff. Please contact Nathan Ajiashvili of Latham & Watkins LLP, counsel to the Company, at +1.212.906.2916, or in his absence, Joshua G. Kiernan at +44.20.7710.5820, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter. [ Signature Page Follows ] Sincerely yours, Alpha Tau Medical Ltd. By: /s/ Uzi Sofer Uzi Sofer Chief Executive Officer cc: Nathan Ajiashvili, Esq. [Signature Page to Acceleration Request]